{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:04:23Z","timestamp":1778292263053,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf02245749","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T10:03:32Z","timestamp":1132049012000},"page":"85-94","source":"Crossref","is-referenced-by-count":153,"title":["Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin"],"prefix":"10.1007","volume":"102","author":[{"given":"Johan A.","family":"Den Boer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G. M.","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245749_CR1","unstructured":"American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. DSM-III"},{"key":"BF02245749_CR2","unstructured":"American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. DSM-III-R"},{"key":"BF02245749_CR3","first-page":"111","volume":"7","author":"GM Bressa","year":"1987","unstructured":"Bressa GM, Marini S, Gregori S (1987) Serotonin S2 receptors blockade and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam. Int J Clin Pharmacol Res 7:111\u2013119","journal-title":"Int J Clin Pharmacol Res"},{"key":"BF02245749_CR4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1176\/ajp.143.4.483","volume":"143","author":"DB Carr","year":"1986","unstructured":"Carr DB, Sheehan DV, Surmon OS et al. (1986) Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Am J Psychiatry 143:483\u2013494","journal-title":"Am J Psychiatry"},{"key":"BF02245749_CR5","doi-asserted-by":"crossref","first-page":"357S","DOI":"10.1111\/j.1365-2125.1983.tb02126.x","volume":"15","author":"S Cella","year":"1983","unstructured":"Cella S, Penalva A, Locatelli V, Novelli A, Cocchi D, M\u00fcller EE (1983) Neuroendocrine studies with fluvoxamine: animal data. Br J Clin Pharmacol 15:357S-363S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02245749_CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1017385","volume":"18","author":"DLS Ceulemans","year":"1985","unstructured":"Ceulemans DLS, Hoppenbrouwers MLJA, Gelders YG et al. (1985) The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind, placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303\u2013305","journal-title":"Pharmacopsychiatry"},{"key":"BF02245749_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000416212","volume":"17","author":"Y Chaput","year":"1988","unstructured":"Chaput Y, Blier P, De Montigny C (1988) Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological, studies in the rat central nervous system. Adv Biol Psychiatry 17:1\u201317","journal-title":"Adv Biol Psychiatry"},{"key":"BF02245749_CR8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archpsyc.1985.01790280040004","volume":"42","author":"DS Charney","year":"1985","unstructured":"Charney DS, Heninger GR (1985a) Noradrenergic function and the mechanism of action of anti-anxiety treatment. I. The effect of long-term alprazolam treatment. Arch Gen Psychiatry 42:458\u2013467","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245749_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1985.01790280055005","volume":"42","author":"DS Charney","year":"1985","unstructured":"Charney DS, Heninger GR (1985b) Noradrenergic function and the mechanisms of action of anti-anxiety treatment. II. The effect of long-term imipramine treatment. Arch Gen Psychiatry 42:473\u2013481","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245749_CR10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.1986.01800110028005","volume":"43","author":"DS Charney","year":"1986","unstructured":"Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 43:1042\u20131054","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245749_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","volume":"41","author":"DS Charney","year":"1984","unstructured":"Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751\u2013763","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245749_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00215473","volume":"92","author":"DS Charney","year":"1987","unstructured":"Charney DS, Woods SW, Goodman WK et al. (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology 92:14\u201324","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR13","doi-asserted-by":"crossref","first-page":"349S","DOI":"10.1111\/j.1365-2125.1983.tb02125.x","volume":"15","author":"V Claassen","year":"1983","unstructured":"Claassen V (1983) Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Clin Pharmacol 15:349S-355S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02245749_CR14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00431683","volume":"86","author":"FC Colpaert","year":"1985","unstructured":"Colpaert FC, Meert TF, Niemegeers CJE et al. (1985) Behavioural and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86:45\u201354","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2125.1986.tb02947.x","volume":"22","author":"K Demisch","year":"1986","unstructured":"Demisch K, Demisch L, Bochnik HJ et al. (1986) Melatonin and cortisol increase after fluvoxamine. Br J Clin Pharmacol 22:620\u2013622","journal-title":"Br J Clin Pharmacol"},{"key":"BF02245749_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02098502","volume":"68","author":"K Demisch","year":"1987","unstructured":"Demisch K, Demisch L, Nichelsen T et al. (1987) The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine. J Neural Transm 68:257\u2013270","journal-title":"J Neural Transm"},{"key":"BF02245749_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004850-198801000-00005","volume":"3","author":"JA Boer Den","year":"1988","unstructured":"Den Boer JA, Westenberg HGM (1988) Effect of serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 3:59\u201374","journal-title":"Int Clin Psychopharmacol"},{"key":"BF02245749_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0165-1781(90)90096-N","volume":"31","author":"JA Boer Den","year":"1990","unstructured":"Den Boer JA, Westenberg HGM (1990) Behavioral, neuroendocrine and biochemical effects of 5-HTP administration in panic disorder. Psychiatry Res 31:267\u2013278","journal-title":"Psychiatry Res"},{"key":"BF02245749_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-198701000-00002","volume":"2","author":"JA Boer Den","year":"1987","unstructured":"Den Boer JA, Westenberg HGM, Kamerbeek WDJ et al. (1987) Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacol 2:21\u201332","journal-title":"Int Clin Psychopharmacol"},{"key":"BF02245749_CR20","first-page":"84","volume":"46","author":"RA Dominguez","year":"1985","unstructured":"Dominguez RA, Goldstein BJ, Jacobson AF et al. (1985) A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychiatry 46:84\u201387","journal-title":"J Clin Psychiatry"},{"issue":"S290","key":"BF02245749_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.1981.tb00737.x","volume":"63","author":"L Evans","year":"1981","unstructured":"Evans L, Moore G (1981) The treatment of phobic anxiety by zimeldine. Acta Psychiatr Scand 63 (S290):342\u2013345","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245749_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0447.1986.tb02666.x","volume":"73","author":"L Evans","year":"1986","unstructured":"Evans L, Kenardy J, Schneider P et al. (1986) Effects of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatr Scand 73:49\u201353","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245749_CR23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0014-2999(70)90229-3","volume":"9","author":"I Geller","year":"1970","unstructured":"Geller I, Blum K (1970) The effects of 5-HTP on para-chlorophenylalanine (p-CPA) attenuation of \u201cconflict\u201d behavior. Eur J Pharmacol 9:319\u2013324","journal-title":"Eur J Pharmacol"},{"key":"BF02245749_CR24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1176\/ajp.138.9.1215","volume":"138","author":"S Gloger","year":"1981","unstructured":"Gloger S, Grunhaus L, Birmacher B et al. (1981) Treatment of spontaneous panic attacks with chlomipramine. Am J Psychiatry 138:1215\u20131217","journal-title":"Am J Psychiatry"},{"key":"BF02245749_CR25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0031-9384(78)90116-6","volume":"21","author":"FG Graeff","year":"1978","unstructured":"Graeff FG, Silveira Filho NG (1978) Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat. Physiol Behav 21:477\u2013484","journal-title":"Physiol Behav"},{"key":"BF02245749_CR26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-3223(89)90217-5","volume":"25","author":"A Hamik","year":"1989","unstructured":"Hamik A, Peroutka J (1989)l-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 25:569\u2013575","journal-title":"Biol Psychiatry"},{"key":"BF02245749_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355","journal-title":"Br J Med Psychol"},{"key":"BF02245749_CR28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278\u2013296","journal-title":"Br J Soc Clin Psychol"},{"key":"BF02245749_CR29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00207228","volume":"93","author":"C Idzikowski","year":"1987","unstructured":"Idzikowski C, Cowen PJ, Nutt D et al. (1987) The effects of chronic ritanserin treatment on sleep and the neuroendocrine response tol-tryptophan. Psychopharmacology 93:416\u2013420","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00004850-198701000-00003","volume":"2","author":"RS Kahn","year":"1987","unstructured":"Kahn RS, Westenberg HGM, Verhoeven WMA et al. (1987) Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Int Clin Psychopharmacol 2:33\u201345","journal-title":"Int Clin Psychopharmacol"},{"key":"BF02245749_CR31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","volume":"96","author":"RS Kahn","year":"1988","unstructured":"Kahn RS, Asnis GM, Wetzler S et al. (1988) Neuroendocrine evidence for a serotonin receptor supersensitivity in panic disorder. Psychopharmacology 96:360\u2013364","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.116.533.387","volume":"116","author":"D Kelly","year":"1970","unstructured":"Kelly D, Guirguis W, Frommer E et al. (1970) Treatment of phobic states with antidepressants. Br J Psychiatry 116:387\u2013398","journal-title":"Br J Psychiatry"},{"key":"BF02245749_CR33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02193476","volume":"5","author":"DF Klein","year":"1964","unstructured":"Klein DF (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5:397\u2013408","journal-title":"Psychopharmacologia"},{"key":"BF02245749_CR34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0010-440X(80)90043-7","volume":"21","author":"DF Klein","year":"1980","unstructured":"Klein DF (1980) Anxiety reconceptualized. Comp Psychiatry 21:411\u2013427","journal-title":"Comp Psychiatry"},{"key":"BF02245749_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1981.tb00756.x","volume":"64","author":"CJ Klok","year":"1981","unstructured":"Klok CJ, Brouwer GJ, Van Praag HM et al. (1981) Fluvoxamine and clomipramine in depressed patients: a double-blind clinical study. Acta Psychiatr Scand 64:1\u201311","journal-title":"Acta Psychiatr Scand"},{"issue":"S290","key":"BF02245749_CR36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-0447.1981.tb00736.x","volume":"63","author":"S Kockzkas","year":"1981","unstructured":"Kockzkas S, Holmberg G, Wedin L (1981) A pilot study of the effect of 5-HT uptake inhibitor, zimeldine, on phobic anxiety. Acta Psychiatr Scand 63 (S290):328\u2013341","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245749_CR37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(87)90058-8","volume":"21","author":"AP Levin","year":"1987","unstructured":"Levin AP, Doran AP, Liebowitz MR et al. (1987) Pituitary adrenocortical unresponsiveness in lactate-induced panic. Psychiatry Res 21:23\u201332","journal-title":"Psychiatry Res"},{"key":"BF02245749_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(85)90022-8","volume":"16","author":"DA Lewis","year":"1985","unstructured":"Lewis DA, Noyes R, Coryell W et al. (1985) Tritiated imipramine binding to platelets is decreased in patients with agoraphobia. Psychiatry Res 16:1\u20139","journal-title":"Psychiatry Res"},{"key":"BF02245749_CR39","first-page":"600","volume":"27","author":"JE Leysen","year":"1985","unstructured":"Leysen JE, Gommeren W, van Gompel P (1985) Receptor binding properties in vitro and in vivo of ritanserin: a very potent and long-acting 5-HT2 antagonist. Mol Pharmacol 27:600\u2013611","journal-title":"Mol Pharmacol"},{"key":"BF02245749_CR40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.143.4.495","volume":"143","author":"MR Liebowitz","year":"1986","unstructured":"Liebowitz MR, Gorman JM, Fyer A et al. (1986) Possible mechanisms for lactate's induction of panic. Am J Psychiatry 143:495\u2013502","journal-title":"Am J Psychiatry"},{"key":"BF02245749_CR41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0005-7967(79)90041-X","volume":"17","author":"IM Marks","year":"1979","unstructured":"Marks IM, Matthews AM (1979) Brief standard self-rating for phobic patients. Behav Res Ther 17:263\u2013267","journal-title":"Behav Res Ther"},{"key":"BF02245749_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0005-7967(86)90154-3","volume":"24","author":"M Mavissakalian","year":"1986","unstructured":"Mavissakalian M (1986) The fear questionnaire: a validity study. Behav Res Ther 24:83\u201385","journal-title":"Behav Res Ther"},{"key":"BF02245749_CR43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00005053-198706000-00006","volume":"175","author":"M Mavissakalian","year":"1987","unstructured":"Mavissakalian M (1987) Initial depression and response to imipramine in agoraphobia. J Nerv Ment Dis 175:358\u2013361","journal-title":"J Nerv Ment Dis"},{"key":"BF02245749_CR44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004714-198402000-00006","volume":"4","author":"M Mavissakalian","year":"1984","unstructured":"Mavissakalian M, Perel JM, Michelson L (1984) The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia. J Clin Psychopharmacol 4:36\u201340","journal-title":"J Clin Psychopharmacol"},{"key":"BF02245749_CR45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/0006-3223(86)90337-9","volume":"21","author":"IM McIntyre","year":"1986","unstructured":"McIntyre IM, Marriott PF, Jefferys D et al. (1986) Melatonin in panic disorder. Biol Psychiatry 21:1438\u20131441","journal-title":"Biol Psychiatry"},{"key":"BF02245749_CR46","unstructured":"Moret C, Briley M (1989) Subsensitivity of the terminal 5-HT autoreceptorfollowing chronic administration with citalopram. In: International Symposium on Serotonin from Cell Biology to Pharmacology and Therapeutics, Florence, Italy, p 90"},{"key":"BF02245749_CR47","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-61-6-1179","volume":"61","author":"EA Mueller","year":"1985","unstructured":"Mueller EA, Murphy DL, Sunderland T (1985) Neuroendocrine effects ofm-Chlorophenylpiperazine, a serotonin agonist in humans. J Clin Endocrinol Metab 61:1179\u20131184","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02245749_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-0327(86)90062-5","volume":"11","author":"TR Norman","year":"1986","unstructured":"Norman TR, Judd FK, Gregory M et al. (1986) Platelet serotonin uptake in panic disorder. J Affective Disord 11:69\u201372","journal-title":"J Affective Disord"},{"key":"BF02245749_CR49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0165-0327(87)90055-3","volume":"12","author":"DJ Nutt","year":"1987","unstructured":"Nutt DJ, Fraser S (1987) Platelet binding studies in panic disorder. J Affective Disord 12:7\u201311","journal-title":"J Affective Disord"},{"key":"BF02245749_CR50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.6251550","volume":"210","author":"SJ Peroutka","year":"1980","unstructured":"Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperodol-labelled serotonin receptor binding. Science 210:88\u201390","journal-title":"Science"},{"key":"BF02245749_CR51","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/0024-3205(82)90670-1","volume":"31","author":"F Petraglia","year":"1982","unstructured":"Petraglia F, Penalva A, Genazzani AR et al. (1982) Stimulation of \u03b2-endorphin and \u03b2-lipotropin release from the anterior but not the neurointermediate pituitary lobe in the rat after acute administration of serotonin-acting drugs. Life Sci 31:2809","journal-title":"Life Sci"},{"key":"BF02245749_CR52","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1210\/jcem-59-6-1138","volume":"59","author":"F Petraglia","year":"1984","unstructured":"Petraglia F, Facchinetti F, Martignoni E et al. (1984) Serotonergic agonists increase plasma levels of \u03b2-endorphin and \u03b2-lipotropin in humans. J Clin Endocrinol Metab 59:1138\u20131142","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02245749_CR53","first-page":"94","volume":"230","author":"E Richelson","year":"1984","unstructured":"Richelson E, Nelson A (1984) Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 230:94\u2013102","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02245749_CR54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0006-3223(87)90130-2","volume":"22","author":"LS Schneider","year":"1987","unstructured":"Schneider LS, Munjack D, Severson JA et al. (1987) Platelet [3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks. Biol Psychiatry 22:59\u201366","journal-title":"Biol Psychiatry"},{"key":"BF02245749_CR55","volume-title":"Test manual for the State-Trait Anxiety Inventory-STAI from Y","author":"CD Spielberger","year":"1980","unstructured":"Spielberger CD (1980) Test manual for the State-Trait Anxiety Inventory-STAI from Y. Consulting Psychologists Press, Palo Alto"},{"key":"BF02245749_CR56","first-page":"299","volume-title":"The benzodiazepines","author":"L Stein","year":"1973","unstructured":"Stein L, Wise CD, Berger BD (1973) Anti-anxiety action of benzodiazepines: decrease in activity of serotonin neurons in the punishment system. In: Garattini S, Mussine E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 299\u2013326"},{"key":"BF02245749_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(80)90183-7","volume":"100","author":"JHH Thijssen","year":"1980","unstructured":"Thijssen JHH, Van den Berg JHM, Adlercreutz J (1980) The determination of cortisol in human plasma: evaluation and comparison of seven assays. Clin Chim Acta 100:39\u201346","journal-title":"Clin Chim Acta"},{"key":"BF02245749_CR58","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0028-3908(79)90036-4","volume":"18","author":"NC Tye","year":"1979","unstructured":"Tye NC, Iversen SA, Green SA (1979) The effects of benzodiazepine and serotonergic manipulations on punished responding. Neuropharmacology 18:689\u2013695","journal-title":"Neuropharmacology"},{"key":"BF02245749_CR59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00422146","volume":"32","author":"P Tyrer","year":"1973","unstructured":"Tyrer P, Candy J, Kelly D (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 32:237\u2013254","journal-title":"Psychopharmacologia"},{"key":"BF02245749_CR60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0006-3223(87)90129-6","volume":"22","author":"TW Uhde","year":"1987","unstructured":"Uhde TW, Berrettini WH, Roy-Byrne PP et al. (1987) Platelet [3H]imi-pramine binding in patients with panic disorder. Biol Psychiatry 22:52\u201358","journal-title":"Biol Psychiatry"},{"key":"BF02245749_CR61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ddr.430080122","volume":"8","author":"JM Nueten Van","year":"1986","unstructured":"Van Nueten JM, Schuurkes JAJ, De Ridder WJE et al. (1986) Comparative pharmacological profile of ritanserin and ketanserin. Drug Dev Res 8:187\u2013195","journal-title":"Drug Dev Res"},{"key":"BF02245749_CR62","volume-title":"Handleiding bij de zelf-beoordelingsvragenlijst","author":"HM Ploeg Van der","year":"1981","unstructured":"Van der Ploeg HM, Defares PB, Spielberger CD (1981) Handleiding bij de zelf-beoordelingsvragenlijst. Swets and Zeitlinger BV, Lisse"},{"key":"BF02245749_CR63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00444706","volume":"98","author":"HGM Westenberg","year":"1989","unstructured":"Westenberg HGM, Den Boer JA (1989) Serotonin function in panic disorder: effect ofl-5-hydroxytryptophan in patients and controls. Psychopharmacology 98:283\u2013285","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00429653","volume":"85","author":"P Willner","year":"1985","unstructured":"Willner P (1985) Antidepressants and serotonergic transmission: an integrative review. Psychopharmacology 85:387\u2013404","journal-title":"Psychopharmacology"},{"key":"BF02245749_CR65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01256471","volume":"64","author":"DT Wong","year":"1985","unstructured":"Wong DT, Reid LR, Bymaster FP, Threlkeld PG (1985) Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64:251\u2013269","journal-title":"J Neural Transm"},{"key":"BF02245749_CR66","doi-asserted-by":"crossref","first-page":"365S","DOI":"10.1111\/j.1365-2125.1983.tb02127.x","volume":"16","author":"K Wood","year":"1983","unstructured":"Wood K, Swade C, Abou-Saleh M et al. (1983) Drug plasma levels and platelet 5-HT uptake inhibition during long-term treatment with fluvoxamine or lithium in patients with affective disorders. Br J Clin Pharmacol 16:365S-368S","journal-title":"Br J Clin Pharmacol"},{"key":"BF02245749_CR67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","volume":"40","author":"CM Zitrin","year":"1983","unstructured":"Zitrin CM, Klein DF, Woerner MG et al. (1983) Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125\u2013138","journal-title":"Arch Gen Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245749.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245749\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:33:28Z","timestamp":1557941608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF02245749"],"URL":"https:\/\/doi.org\/10.1007\/bf02245749","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}